Global Compounding Pharmacy Market Outlook, 2029

The Global Compounding Pharmacy Market is estimated at USD 14.81 billion in 2031 , driven by Surging Prevalence of Chronic Diseases.

According to publisher, Here is the Global Compounding Pharmacy Market Report. Market Insights The global compounding pharmacy market is expected to reach a staggering USD 14.82 billion by 2031, growing at a healthy CAGR of 6.2%. This growth is fueled by a rising demand for personalized medications to address specific patient needs.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Market Dynamics Several factors are propelling the compounding pharmacy market forward: Surging Prevalence of Chronic Diseases: Chronic illnesses like diabetes, cancer, and heart disease are on the rise. This creates a need for customized medications, particularly for patients with allergies or swallowing difficulties, which can be catered to by compounding pharmacies. For instance, a 2019 report by the CDC highlighted that over 20% of US adults suffer from chronic pain, a condition often managed through compounded medications. Increasing Geriatric Population: An aging population globally, particularly in Europe, necessitates effective medication management for multiple chronic conditions. Compounding pharmacies can combine medications into single doses, improving adherence for elderly patients. The World Health Organization predicts that by 2050, over 40 million Europeans will be 85 or older, many requiring such services. Personalized Medicine Boom: The growing focus on personalized medicine, which tailors treatment plans to individual genetics and lifestyle factors, creates opportunities for compounding pharmacies. They can create customized dosage forms and strengths based on a patient's unique needs. Market Segments The compounding pharmacy market can be segmented based on various factors: Therapeutic Area: Pain management holds the largest market share (over 33% in 2021) due to the high prevalence of chronic pain conditions. Other segments include dermatology, hormone replacement, and nutritional deficiencies. Product Type: Oral medications dominate the market, followed by topical creams, suppositories, and injectables. The choice depends on the medication and the patient's needs. Regional Analysis North America is a significant market leader due to high healthcare spending and an established compounding infrastructure. However, Asia Pacific is expected to witness the fastest growth due to a rising geriatric population and increasing disposable incomes. Europe is another prominent market with stringent regulations ensuring medication quality.

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Key Developments The compounding pharmacy market is constantly evolving. Examples include: Technological Advancements: Automation and robotics are being integrated into compounding processes to improve accuracy, efficiency, and sterility. Increased Regulatory Scrutiny: Regulatory bodies are implementing stricter guidelines to ensure the safety and efficacy of compounded medications. Competitive Landscape The compounding pharmacy market is a competitive landscape with both independent and chain pharmacies vying for market share. Key players include Adamas Pharmaceuticals, L Perrigo Company, and PharMerica Corporation. Mergers and acquisitions are expected to drive further market consolidation. In conclusion, the global compounding pharmacy market is flourishing due to rising patient needs for personalized medications. As chronic diseases and the geriatric population grow, compounding pharmacies are well-positioned to cater to this growing demand.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Table of Contents

  • Table Of Contents
  • Figures And Tables
  • Part 1. Introduction
  • 1.1 Description
  • 1.2 Objectives Of The Study
  • 1.3 Market Segment
  • 1.4 Years Considered For The Report
  • 1.5 Currency
  • 1.6 Key Target Audience
  • Part 2. Research Methodology
  • 2.1 Primary Research
  • 2.2 Secondary Research
  • Part 3. Executive Summary
  • Part 4. Market Overview
  • 4.1 Introduction
  • 4.2 Drivers
  • 4.3 Restraints
  • Part 5. Global Compounding Pharmacy Market By Therapeutic Area
  • 5.1 Pain Management
  • 5.2 Hormone Replacement
  • 5.3 Dermal Disorders
  • 5.4 Nutritional Supplements
  • 5.5 Others
  • Part 6. Global Compounding Pharmacy Market By Route Of Administration
  • 6.1 Oral
  • 6.2 Topical
  • 6.3 Parenteral
  • 6.4 Others
  • Part 7. Global Compounding Pharmacy Market By End User
  • 7.1 Humans
  • 7.2 Veterinary
  • Part 8. Global Compounding Pharmacy Market By Region
  • 8.1 North America
  • 8.2 Europe
  • 8.3 Asia-Pacific
  • 8.4 Mea (Middle East And Africa)
  • 8.5 Latin America
  • Part 9. Company Profiles
  • 9.1 B. Braun Melsungen Ag
  • 9.2 Dougherty'S Pharmacy Inc.
  • 9.3 Fagron Nv
  • 9.4 Fresenius Se & Co. Kgaa
  • 9.5 Institutional Pharmacy Solutions Llc
  • 9.6 Nephron Pharmaceuticals Corporation
  • 9.7 Pharmasave Drugs (National) Ltd.
  • 9.8 Valor Compounding Pharmacy Inc.
  • 9.9 Wedgewood Village Pharmacy Llc
  • Disclaimer


Global Compounding Pharmacy Market Outlook, 2029

Contact usWe are friendly and approachable, give us a call.